Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

NCT05161533 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Closed per SRC Low Accrual Policy. Study closed prior to any participants enrolled.

Conditions

Extensive Stage Lung Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8

Interventions

DRUG: Carboplatin
DRUG: Cisplatin
BIOLOGICAL: Durvalumab
DRUG: Etoposide
RADIATION: Hypofractionated Radiation Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

University of Washington

Collaborators

[object Object]